Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001493152-22-018942
Filing Date
2022-07-08
Accepted
2022-07-08 17:30:57
Documents
1
Effectiveness Date
2022-07-08
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11539
  Complete submission text file 0001493152-22-018942.txt   12779
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

EIN.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-451712 | Film No.: 221075374
SIC: 2834 Pharmaceutical Preparations